mitomycin has been researched along with acetylcysteine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (40.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 5 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gustafson, DL; Pritsos, CA | 1 |
Hamilton, JW; Maccubbin, AE; Warren, AJ | 1 |
Banks, L; Mantovani, F | 1 |
Benbow, U; Brinckerhoff, CE; Hamilton, JW; Maitra, R | 1 |
Eliashar, R; Hirshoren, N | 1 |
Adair, J; Beard, BC; Becker, PS; Chien, S; Kiem, HP; Kohn, DB; Shimamura, A; Taylor, JA; Trobridge, GD; Wagner, JE; Zhao, X | 1 |
Daneker, GW; Kim, B; McDonald, JF; Mezencev, R; Sulchek, TA; Wang, L; Xu, W | 1 |
Dokal, I; Hossain, U; Jackson, N; Kirwan, M; Plagnol, V; Pondarre, C; Tummala, H; Vulliamy, T; Walne, AJ | 1 |
2 review(s) available for mitomycin and acetylcysteine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Wound-healing modulation in upper airway stenosis-Myths and facts.
Topics: Acetylcysteine; Aminopropionitrile; Animals; Antimetabolites; Colchicine; Fluorouracil; Humans; Hyperbaric Oxygenation; Laryngostenosis; Mitomycin; Nucleic Acid Synthesis Inhibitors; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Secondary Prevention; Wound Healing | 2009 |
8 other study(ies) available for mitomycin and acetylcysteine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.
Topics: Acetylcysteine; Aerobiosis; Animals; Antineoplastic Agents; Antioxidants; Azoles; Cell Hypoxia; Cell Line; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Isoindoles; Mice; Mitomycin; Mitomycins; Organoselenium Compounds; Porfiromycin; Selenium; Tumor Cells, Cultured | 1991 |
Detection of mitomycin C-DNA adducts in vivo by 32P-postlabeling: time course for formation and removal of adducts and biochemical modulation.
Topics: Acetylcysteine; Animals; Biotransformation; Buthionine Sulfoximine; Chick Embryo; Cross-Linking Reagents; Dexamethasone; DNA; DNA Adducts; DNA Damage; DNA Repair; Enzyme Induction; Ethacrynic Acid; Glutathione; Glutethimide; Inactivation, Metabolic; Kidney; Liver; Lung; Mitomycin; Phosphorus Radioisotopes; Polychlorinated Biphenyls; Time Factors | 1998 |
Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
Topics: Acetylcysteine; Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma; Cell Nucleus; Cysteine Proteinase Inhibitors; DNA Damage; DNA-Binding Proteins; Female; Fibrosarcoma; Humans; Leupeptins; Mitomycin; Oncogene Proteins, Viral; Papillomaviridae; Polymorphism, Genetic; Repressor Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Uterine Cervical Neoplasms | 1999 |
Selective inhibition of collagenase-1, gelatinase A, and gelatinase B by chemotherapeutic agents.
Topics: Acetylcysteine; Antineoplastic Agents; Carboplatin; Cisplatin; Doxorubicin; Gelatinases; Humans; Matrix Metalloproteinase 1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Melanoma; Metalloendopeptidases; Mitomycin; Neoplasm Invasiveness; Protease Inhibitors; Tumor Cells, Cultured | 1999 |
Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.
Topics: Acetylcysteine; Bone Marrow Cells; Fanconi Anemia; Fanconi Anemia Complementation Group A Protein; Genetic Therapy; Genetic Vectors; Hematopoietic Stem Cells; Humans; Lentivirus; Mitomycin; Transduction, Genetic | 2010 |
Molecular analysis of the inhibitory effect of N-acetyl-L-cysteine on the proliferation and invasiveness of pancreatic cancer cells.
Topics: Acetylcysteine; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; G1 Phase Cell Cycle Checkpoints; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; Mitomycin; Pancreatic Neoplasms; Reactive Oxygen Species | 2013 |
ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function.
Topics: Acetylcysteine; Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cell Line, Tumor; Cell Nucleus; Cell Survival; DNA Damage; DNA Helicases; DNA Repair; Female; Gene Knockdown Techniques; HEK293 Cells; HeLa Cells; Hemoglobinuria, Paroxysmal; Histones; Humans; Male; Mitochondria; Mitomycin; Mutation; Pedigree; Phosphorylation; Reactive Oxygen Species; Sesquiterpenes | 2014 |